Sodium Polystyrene Sulfonate
These highlights do not include all the information needed to use SODIUM POLYSTYRENE SULFONATE POWDER FOR SUSPENSION safely and effectively. See full prescribing information for SODIUM POLYSTYRENE SULFONATE POWDER FOR SUSPENSION SODIUM POLYSTYRENE SULFONATE POWDER FOR SUSPENSION for oral or rectal use Initial U.S. Approval: 1958
Approved
Approval ID
024b9f0b-42f0-42dd-ac2b-b46e15e45440
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 3, 2022
Manufacturers
FDA
ECI Pharmaceuticals, LLC
DUNS: 962476029
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Polystyrene Sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51293-831
Application NumberANDA090313
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateDecember 27, 2020
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR